Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
2019
Leitung: Prof. Dr. Danilo Fliser

Publikationen 2019

Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlik I, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.

Nephrol Dial Transplant. 2019. Impact Punkte: 4,2 Abstract


Schmit D, Fliser D, Speer T.

Proprotein convertase subtilisin/kexin type 9 in kidney disease.

Nephrol Dial Transplant. 2019. Impact Punkte: 4,2 Abstract


Schunk SJ, Zarbock A, Meersch M, Kullmar M, Kellum JA, Schmit D, Wagner M, Triem S, Wagenpfeil S, Grone HJ, Schafers HJ, Fliser DZewinger S, Speer T.

Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study.

Lancet. 2019. Impact Punkte: 59,1 Abstract


Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fahndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jorres RA, Bals R.

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.

Respir Med. 2019;154:18-26. Impact Punkte: 3,2 Abstract


Pecoits-Filho R, Fliser D, Tu C, Zee J, Bieber B, Wong MMY, Port F, Combe C, Lopes AA, Reichel H, Narita I, Stengel B, Robinson BM, Massy Z.

Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care.

J Clin Hypertens (Greenwich). 2019.  Impact Punkte: 2,4 Abstract

 

Hamza A, Gerlinger C, Radosa J, Solomayer EF, Hagmann J, Sester U, Bohle R, Stroeder R, Takacs Z, Meyberg-Solomayer G, Juhasz-Boess I, Kasoha M.

Pilot study: placental biomarker predictive capability (sFlt-1, PlGF and their ratio) of postpartum maternal outcome.

Arch Gynecol Obstet. 2019;299(6):1557-1566. Impact Punkte: 2,2 Abstract

 

Bomberg H, Stroeder J, Karrenbauer K, Groesdonk HV, Wagenpfeil S, Klingele M, Bucker A, Schafers HJ, Minko P.

Establishment of Predictive Models for Nonocclusive Mesenteric Ischemia Comparing 8,296 Control with 452 Study Patients.

J Cardiothorac Vasc Anesth. 2019;33(5):1290-1297. Impact Punkte: 1,9 Abstract

 

Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutierrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauss S, Konig M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlik I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G.

Mild cognitive impairment and kidney disease: clinical aspects.

Nephrol Dial Transplant. 2019. Impact Punkte: 4,2 Abstract

 

Weingartner O, Lutjohann D, Meyer S, Fuhrmann A, Cremers B, Seiler-Mussler S, Schott HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada A, Laufs U, Schulze PC, Scheller B, Fliser D, Bohm M, Sijbrands E, Heine GH.

Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study.

Clin Res Cardiol. 2019. Impact Punkte: 4,9 Abstract

 

Brandenburg V, Heine GH.

[The Cardiorenal Syndrome].

Dtsch Med Wochenschr. 2019;144(6):e2. Impact Punkte: 0,6 Abstract

 

Brandenburg V, Heine GH.

[The Cardiorenal Syndrome].

Dtsch Med Wochenschr. 2019;144(6):382-386. Impact Punkte: 0,6 Abstract

 

Emrich IE, Baier M, Zawada AM, Meyer T, Fliser D, Scharhag J, Heine GH.

Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation.

Clin Res Cardiol. 2019;108(3):341-343. Impact Punkte: 4,9 Abstract

 

Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.

Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.

Am J Nephrol. 2019;49(3):203-211. Impact Punkte: 3,0 Abstract

 

Zoccali C, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Massy Z, Rychlik I, Soler M, Stevens K, Spasovski G, Wanner C.

Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials.

Nephrol Dial Transplant. 2019. Impact Punkte: 4,2 Abstract

 

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Author Correction: Lipid management in patients with chronic kidney disease.

Nat Rev Nephrol. 2019;15(2):121. Impact Punkte: 19,7 Abstract

 

Emrich IE, Vodovar N, Feuer L, Untersteller K, Nougue H, Seiler-Mussler S, Fliser D, Launay JM, Heine GH.

Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?

Nephrol Dial Transplant. 2019;34(1):100-108. Impact Punkte: 4,2Abstract

 

Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Massy Z, Rychlik I, Soler MJ, Spasovski G, Stevens K, Wanner C, Zoccali C.

Lancet Countdown paper: what does it mean for nephrology?

Nephrol Dial Transplant. 2019;34(1):4-6. Impact Punkte: 4,2 Abstract